Venlafaxine Hydrochloride Capsule, Extended Release
Product Images NDC 50090-7940

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Venlafaxine Hydrochloride (NDC 50090-7940). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label Image (Lbl500907940)

Venlafaxine Hydrochloride Extended-Release 37.5 mg capsules label from A-S Medication Solutions. The label includes product number G6468-0 and NDC code 50090-7940-0. It specifies the oral dosage form as extended-release capsules, packaged as 30 capsules. Storage instructions recommend keeping at 68 to 77 degrees Fahrenheit.*

FDA Label Image

Figure (Venlafaxine Fig1)

A scatter plot illustrating pharmacokinetic (PK) fold changes with 90% confidence intervals for venlafaxine and its O-desmethylvenlafaxine (ODV) metabolite across various special populations, including hepatic impairment, renal impairment, CYP2D6 polymorphism, age over 60, and gender differences. The x-axis represents change relative to the reference value, and the y-axis lists each population and analyte with Cmax and AUC parameters.*

FDA Label Image

Figure (Venlafaxine Fig2)

A scatter plot chart showing the fold change and 90% confidence intervals of pharmacokinetic parameters (Cmax and AUC) for venlafaxine hydrochloride interacting with various drugs, including ethanol, diazepam, cimetidine, ketoconazole, indinavir, metoprolol, imipramine, and lithium. The x-axis represents change relative to the reference value, and the y-axis lists interacting drugs and analyte details.*

FDA Label Image

Figure (Venlafaxine Fig3)

A pharmacokinetic chart showing fold changes and 90% confidence intervals for various analytes influenced by interacting drugs, including ethanol, diazepam, alprazolam, indinavir, metoprolol, risperidone, imipramine, haloperidol, caffeine, tolbutamide, and lithium. The x-axis represents fold change relative to a reference value, and the y-axis lists the analytes and their pharmacokinetic measures (Cmax and AUC).*

FDA Label Image

Chemical Structure (Venlafaxine Str)

Chemical structure of venlafaxine hydrochloride showing its molecular arrangement including the cyclohexanol moiety, dimethylaminoethyl side chain, and methoxyphenyl group along with the hydrochloride salt representation.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.